About this trial
Chronic gastritis (CG) is a prevalent and persistent inflammatory condition that affects the gastric mucosa, carrying a significant global burden. Although CG may remain asymptomatic in some cases, many patients experience gastrointestinal (GI) symptoms such as epigastric pain, bloating, nausea, vomiting, and appetite loss.
Diet plays a crucial role in both the development and progression of CG. there is a significant relationship between dietary behaviors, GI symptoms, and quality of life (QoL) in CG patients. Poor dietary habits have been associated with increased symptom severity, while healthier eating behaviors correlate with better physical and mental well-being.
Most research has focused on dietary risk factors in gastric cancer patients, with limited studies exploring their impact on CG and its symptoms. Furthermore, while nutritional adjustments are frequently recommended in clinical practices such as reducing coffee and alcohol intake and avoiding heavy smoking, there is a lack of comprehensive studies evaluating the relationship between eating habits, food preferences, and symptom severity in CG patients
Eligibility criteria
Qualifiers
• Adults aged 18 years or above
All consecutive patients with gastrointestinal symptoms for a week or longer.
Disqualifiers
Subjects who reported having other digestive system diseases such as peptic ulcer, pancreatitis, hepatitis, and cirrhosis
Serious heart, brain, liver, kidney, or hematopoietic system dysfunction or other serious diseases
Severe mental illness (such as schizophrenia, depression, and anxiety)
Food or drug allergies, pregnancy, or breastfeeding
Trial design
Treatments tested in this trial
- Observation